Results 1 to 10 of about 302,174 (119)
Pretrained models may fail to capture immunological sequences [PDF]
Pretrained models, originally developed for vision and textual data, are not a panacea and may fail to fully represent the complexity of sequences in immunological tasks.
Jiahao Ma +4 more
doaj +2 more sources
The antigenicity as well as the immunogenicity of tumor associated antigens (TAAs) may need to be potentiated in order to break the immunological tolerance.
Beatrice Cavalluzzo +9 more
doaj +1 more source
Molecular mimicry and cancer vaccine development
Background The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift and potent anti-tumor immune response.
Maria Tagliamonte +6 more
doaj +1 more source
The host’s immune system may be primed against antigens during the lifetime (e.g. microorganisms antigens—MoAs), and swiftly recalled upon growth of a tumor expressing antigens similar in sequence and structure.
Angela Mauriello +9 more
doaj +1 more source
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
Background People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry between HIV epitopes and tumor associated antigens ...
Carmen Manolio +10 more
doaj +1 more source
Background The host’s immune system develops in equilibrium with both cellular self-antigens and non-self-antigens derived from microorganisms which enter the body during lifetime. In addition, during the years, a tumor may arise presenting to the immune
Luigi Buonaguro +11 more
doaj +1 more source
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Background The gut microbiota profile is unique for each individual and are composed by different bacteria species according to individual birth-to-infant transitions.
Concetta Ragone +7 more
doaj +1 more source
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
Virus-like particles (VLPs) are self-assembled viral protein complexes that mimic the native virus structure without being infectious. VLPs, similarly to wild type viruses, are able to efficiently target and activate dendritic cells (DCs) triggering the ...
Anna Lucia Tornesello +4 more
doaj +1 more source
MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
Tumor Associated Antigens (TAAs) may suffer from an immunological tolerance due to expression on normal cells. In order to potentiate their immunogenicity, heteroclitic peptides (htcPep) were designed according to prediction algorithms.
Maria Tagliamonte +16 more
doaj +1 more source
Selecting Target Antigens for Cancer Vaccine Development
One of the principal goals of cancer immunotherapy is the development of efficient therapeutic cancer vaccines that are able to elicit an effector as well as memory T cell response specific to tumor antigens.
Luigi Buonaguro, Maria Tagliamonte
doaj +1 more source

